Leica Microsystems, Inc. recalls BOND Ready-To-Use Primary Antibody CDX2 (EP25), REF PA0375
- Recall date
- July 30, 2021
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Recall number
- Z-2481-2021
- FDA classification
- Class II
- Brand / firm
- Leica Microsystems, Inc.
- Sold / distributed
- US Nationwide distribution.
Why it was recalled
Product may not perform as specified in IFU.
Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What was recalled
BOND Ready-To-Use Primary Antibody CDX2 (EP25), REF PA0375
Get recall alerts
Free email alert whenever Leica Microsystems, Inc. has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: Leica Microsystems, Inc.